DENVER, Feb. 3, 2011 (GLOBE NEWSWIRE) -- MusclePharm(R) Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, announced on Thursday that its revolutionary MuscleGel® product will now be available in 1,500 General Nutrition Center (GNC) stores later this month.
GNC is the largest specialty retailer of nutritional products in the world, featuring locations throughout the United States and in numerous international markets, giving even greater exposure to an innovative gel-based protein product that has already earned high marks in the industry.
"I am excited to get MuscleGel in GNC so we can get this amazingly convenient product in our customer's hands," MusclePharm President Cory Gregory said.
"This product is unique and it is truly one-of-a-kind in this market. It meets a huge need for our consumers, who all lead a busy lifestyle and need a fast alternative to a protein shake and better quality nutrition than a protein bar, and are confident it will be a game-changer in this industry."
MuscleGel signifies a previously untapped area in the supplement world, offering high-quality protein in a convenient gel-based formula that makes it simple to consume on the go without the hassle of liquids or mixing. Its unique ProFusion Technology enhances the body's ability to absorb nutrients thanks to its nutritional delivery system, offering a great taste and numerous health benefits.
MusclePharm®'s MuscleGel® is a gel based supplement that enhances the body's ability to absorb nutrients, ensures a consistent delivery of hydrated nutrients every time, provides a soothing effect to the digestive system, and tastes great. MuscleGel® uses MusclePharm's ProFusion™ Technology, an entirely new and exciting patent-pending nutritional delivery system that revolutionizes the way our bodies absorb, metabolize and benefit from nutritional supplementation, and is packaged in a portable convenient gel pack, that makes it easy to consume on the go, without the use of liquids or mixing.
Since its introduction in 2010, MuscleGel has drawn impressive reviews by consumers from all walks of life, including Ultimate Fighting Championship (UFC) superstar and former light heavyweight champion Rashad Evans.
"MuscleGel is the best invention since sliced bread," Evans joked.
"On a serious note, though, the most inconvenient thing about taking protein is all the messy shaker cups and clean-up. With MuscleGel, that isn't a concern. In this market, there is no better way to take your protein than with MuscleGel."
ABOUT MUSCLEPHARM
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit www.musclepharm.com.
Forward-looking Statements
MusclePharm Corporation believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Item 2.02 of the Company's Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission.